Reading Time: 2 minutesIntroduction to Semaglutide Semaglutide, a medication initially approved for the treatment of type 2 diabetes, has recently garnered significant attention for its potential benefits in weight management. As healthcare professionals and patients alike seek effective interventions for obesity, understanding the mechanisms, efficacy, and safety of semaglutide is crucial. This article aims to dissect the clinical insights and dispel common misconceptions surrounding this promising therapeutic option. Mechanism of Action Semaglutide operates primarily by mimicking the activity of glucagon-like peptide-1 (GLP-1), a hormone involved in appetite regulation and calorie intake. By binding to GLP-1 receptors, semaglutide enhances insulin secretion, suppresses glucagon release, … Continue reading →